Business
Currency:EUR
2023/FY
Stock NameRevenueRatio
IXIARO®73.48M47.81%
Third party products35.68M23.21%
DUKORAL®29.78M19.37%
COVID VLA20017.66M4.99%
Others3.09M2.01%
IXCHIQ2.73M1.78%
Other non-IFRS 15 revenue1.01M0.66%
Services related to clinical trial material275K0.18%
View all
Region
Currency:EUR
2023/FY
Stock NameRevenueRatio
United States32.96M21.45%
Canada28.19M18.34%
United Kingdom20.27M13.18%
Rest of world16.31M10.61%
Austria14.58M9.49%
Germany13.5M8.78%
Nordics12.7M8.26%
Other Europe9.34M6.07%
France5.87M3.82%
View all
